o Current CEO Geir Almås proposed as new chairman of SoftOx Solutions AS 
o Three additional board members proposed - Henrik Nielsen, Adrian Bignami and
Jørgen Berggrav 

Oslo, Norway - 2 December 2022:  The board of directors of SoftOx Solutions AS
("SoftOx" or the "Company"), a medtech and clinical-stage pharmaceutical company
based in Oslo, Norway, hereby convenes, upon the request of certain large
shareholders (including the CEO, Geir Almås), an extraordinary general meeting
to be held on 9 December 2022 for the election of a new chairman and new board
members. 

The notice to the EGM and the proposal from the shareholders are attached. A
summary of the shareholders proposal is included in the following:   

"After several major achievements in the past half year including the European
Defence Fund grant and successful completion of Phase 1 of the SoftOx Biofilm
Eradicator, the Company's largest shareholders, representing 26 per cent of the
total number of outstanding shares, have proposed changes to the current Board
of Directors and management team.  The shareholder group, including Dinge Invest
AS, Hermod Farms AS, Kristian Almås, Almhaug Bolig AS, all companies associated
with Kristian and Geir Almås, proposes that CEO Geir Hermod Almås step down from
his current role as CEO and transition to chairman of SoftOx.  

To further strengthen both the board of directors and management team, the
shareholder group proposes the addition of Henrik Nielsen, Adrian Bignami and
Jørgen Berggrav as elected members of the board. Together with the existing
members Kari Myren and Olav Jarlsby, the new members will represent an
international board with interests and expertise reflective of the company's
current and future business pursuits. 

Henrik J. Nielsen is the founder and CEO of CAP Partner, a conference handling
and consulting firm based in Frederiksberg, Denmark, and Director of the
European Wound Management Association, which is one of the largest
not-for-profit umbrella organisations in the world within the field of
scientific and clinical wound care. Nielsen is an expert in association
management, advocacy, fundraising and organization and has provided many years
of expertise in the medical device area as a consultant.  

Adrian Bignami is one of the early co-inventors of the SoftOx technology and is
currently the Vice President of Finance, Business Planning and Analysis at C4
Therapeutics, Inc., a clinical-stage biotechnology company in the US. He has
over 20 years of experience in management consulting, investment banking,
entrepreneurship, business development and corporate finance across the
pharmaceutical and biotechnology sectors. 

Jørgen Berggrav (Rear Admiral Rtd) has served as the Senior Advisor of SoftOx
Defense Solutions since September 2022. Berggrav has held many diverse roles in
the Armed Forces including as Director General in the Ministry of Defence,
representative of Europe to the Supreme Allied Commander Transformation and
representative of the Chief of Defence at NATO's operational command, SHAPE. 

SoftOx Solutions AS hereby calls for an Extraordinary General Meeting (EGM) to
be held at Martin Linges vei 25, 1364 Fornebu on 9 December 2022 at 12:00 hours
(CET). Shareholders are encouraged to submit proxies with or without voting
instructions in advance of the general meeting." 

Shareholders wishing to attend the Extraordinary General Meeting, in person or
by proxy, must complete and return the attendance form or proxy form to the
SoftOx IR email ir@soft-ox.com no later than 8 December 2022 at 12:00. 

The notice of the EGM is attached. All documents regarding the EGM are also
available on the Company's website:
https://soft-ox.com/stock-market-announcements/  

 
The following items are on the agenda: (i) Election of new Chair of the Board of

Directors and changes to the board (ii) Remuneration to the chair of the board
and board members. 
 
For further information, please contact:  
Geir Almås, CEO of SoftOx Solutions AS  
Mail: ir@soft-ox.com  
Phone: Front Desk: (+47) 948-59-599  

About SoftOx Solutions AS  
SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a medtech and
clinical-stage pharmaceutical company based in Oslo, Norway, with the goal of
reducing the spread of infection and emergence of antimicrobial resistance.  

For more information on SoftOx, visit www.soft-ox.com